ARS Pharmaceuticals (SPRY) Intangibles (2024 - 2026)
ARS Pharmaceuticals (SPRY) reported Intangibles of $14.2 million for Q1 2026, up 5547.81% on a YoY basis from $251000.0 in Q1 2025, and down 1.91% sequentially from $14.5 million in Q4 2025.
ARS Pharmaceuticals (SPRY) Intangibles (2024 - 2026) Analysis & Trends
ARS Pharmaceuticals (SPRY) has 3 years of Intangibles data on file, last reported at $14.2 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles rose 5547.81% year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 million (up 5547.81% YoY), and the FY2025 full-year result was $14.5 million, up 96.07% from the prior year.
- Intangibles slipped to $14.2 million in Q1 2026, from $14.5 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $14.5 million in Q4 2025 to a low of $125000.0 in Q3 2025.
- A 3-year average of $6.4 million and a median of $7.4 million in 2024 frame the typical range for Intangibles.
- Across the five-year window, Intangibles slumped 98.33% in 2025 and surged 5547.81% in 2026, its largest moves.
- Tracing SPRY's Intangibles over 3 years: stood at $7.4 million in 2024, then surged by 96.07% to $14.5 million in 2025, then decreased by 1.91% to $14.2 million in 2026.
- Business Quant data shows SPRY's Intangibles at $14.2 million in Q1 2026, $14.5 million in Q4 2025, and $125000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | ARS Pharmaceuticals | 595.78 Mn | 394.81 Mn | - | 14.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.18 Mn |
| Dec 31, 2025 | 14.45 Mn |
| Sep 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 12.97 Mn |
| Mar 31, 2025 | 251,000.00 |
| Dec 31, 2024 | 7.37 Mn |
| Sep 30, 2024 | 7.50 Mn |
| Jun 30, 2024 | 446,000.00 |
| Mar 31, 2024 | 528,000.00 |